Science Explorer Back to mapMap
Discussion
Company · Binningen · Switzerland

Develco Pharma (Switzerland)

develco.ch/enROR OpenAlex
Research works
8
▲ 108% vs 2018-21
Citations
38
5.0 per fractional work
Top-10% rate
5.8%
all institutions 10.0%
Open access
64%
world 40%
International
74%
world 18%
Develco Pharma (Switzerland)

Not ranked overall: Develco Pharma (Switzerland) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Develco Pharma (Switzerland) work in?

In all years, 60% of research at Develco Pharma (Switzerland) is in Health Sciences, 18% in Life Sciences. Its largest fields are Medicine (60%), Neuroscience (15%), Social Sciences (9%). It does 1.6× the world's share of Health Sciences.

Health Sciences: 5 fractional works · 60.0% of its workMedicine: 5 fractional works · 60.0% of its workPharmacology: 2 fractional works · 23.4% of its workAnesthesiology and Pain Medicine: 1 fractional works · 12.1% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 5.5% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 5.3% of its workSurgery: 0 fractional works · 3.7% of its workGastroenterology: 0 fractional works · 2.9% of its workFamily Practice: 0 fractional works · 2.2% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 1.1% of its workEpidemiology: 0 fractional works · 1.1% of its workGeriatrics and Gerontology: 0 fractional works · 1.1% of its workPsychiatry and Mental health: 0 fractional works · 1.1% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.5% of its workLife Sciences: 1 fractional works · 17.7% of its workNeuroscience: 1 fractional works · 14.5% of its workBiological Psychiatry: 0 fractional works · 5.1% of its workCognitive Neuroscience: 0 fractional works · 3.3% of its workDevelopmental Neuroscience: 0 fractional works · 2.0% of its workCellular and Molecular Neuroscience: 0 fractional works · 1.7% of its workBehavioral Neuroscience: 0 fractional works · 1.1% of its workNeurology: 0 fractional works · 0.7% of its workSensory Systems: 0 fractional works · 0.7% of its workBiochemistry, Genetics and Molecular Biology: 0 fractional works · 2.2% of its workMolecular Biology: 0 fractional works · 2.2% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.9% of its workPharmacology: 0 fractional works · 0.9% of its workSocial Sciences: 1 fractional works · 12.9% of its workSocial Sciences: 1 fractional works · 8.8% of its workSociology and Political Science: 0 fractional works · 4.4% of its workTransportation: 0 fractional works · 4.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPsychology: 0 fractional works · 4.1% of its workExperimental and Cognitive Psychology: 0 fractional works · 3.3% of its workApplied Psychology: 0 fractional works · 0.8% of its workPhysical Sciences: 1 fractional works · 9.4% of its workEngineering: 1 fractional works · 8.4% of its workAerospace Engineering: 0 fractional works · 4.4% of its workBiomedical Engineering: 0 fractional works · 2.2% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 1.1% of its workOcean Engineering: 0 fractional works · 0.9% of its workComputer Science: 0 fractional works · 0.9% of its workComputational Theory and Mathematics: 0 fractional works · 0.9% of its workALL ITS WORKDevelco Pharma(Switzerland)8fractional works, all years
Life Sciences18%Physical Sciences9%Health Sciences60%Social Sciences13%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 8 fields, with their numbers
    1. Medicine560.0%
    1. Neuroscience114.5%
    2. Biochemistry, Genetics and Molecular Biology02.2%
    3. Pharmacology, Toxicology and Pharmaceutics00.9%
    1. Social Sciences18.8%
    2. Psychology04.1%
    1. Engineering18.4%
    2. Computer Science00.9%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from Develco Pharma (Switzerland)?

The most cited paper from Develco Pharma (Switzerland) is "Avosentan for Overt Diabetic Nephropathy" (Johannes F.E. Mann, Damian Green, Kenneth Jamerson et al., 2010), with 493 citations. Next come "Extended‐release but not immediate‐release and subcutaneous methylnaltrexone antagonizes the loperamide‐induced delay of whole‐gut transit time in healthy subjects" (19) and "Chiral Pharmacokinetics and Metabolite Profile of Prolonged-release Ketamine Tablets in Healthy Human Subjects" (13).

Most cited papers
#PaperReleasedCitations
1 Avosentan for Overt Diabetic Nephropathy Johannes F.E. Mann, Damian Green, Kenneth Jamerson et al. · Journal of the American Society of Nephrology Open access 18 Feb 2010 493
2 Extended‐release but not immediate‐release and subcutaneous methylnaltrexone antagonizes the loperamide‐induced delay of whole‐gut transit time in healthy subjects Julia Kolbow, Christiane Modeß, Danilo Wegner et al. · The Journal of Clinical Pharmacology 27 Aug 2015 19
3 Chiral Pharmacokinetics and Metabolite Profile of Prolonged-release Ketamine Tablets in Healthy Human Subjects Mahmoud Hasan, Christiane Modeß, Tarek Roustom et al. · Anesthesiology 21 May 2021 13
4 Clinical evaluation of the first oxycodone once daily prolonged release tablet in moderate to severe chronic pain: a randomized, double-blind, multicenter, cross-over, non-inferiority study to investigate efficacy and safety in comparison with an established oxycodone twice daily prolonged release tablet Eberhard Albert Lux, Marcin Janecki, Martina Alice Maritz · Current Medical Research and Opinion Open access 22 Jul 2014 9
5 Once‐Daily Oxycodone Prolonged‐Release Tablets Are Resistant to Alcohol‐Induced Dose Dumping: Results From a Randomized Trial in Healthy Volunteers Nils Burger, Douglas Fraser, Martina Alice Maritz et al. · Clinical and Translational Science Open access 6 Feb 2020 8
All 17 most cited papers, with filters and sorting

Which research topics does Develco Pharma (Switzerland) publish most on?

By volume in 2022-now: Treatment of Major Depression, Tryptophan and brain disorders, Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes and Pain Management and Placebo Effect.

Treatment of Major Depre…1Treatment of Major Depression: 1 fractional worksTryptophan and brain disorders: 0 fractional worksAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes: 0 fractional worksPain Management and Placebo Effect: 0 fractional worksDigital Mental Health Interventions: 0 fractional worksFunctional Brain Connectivity Studies: 0 fractional worksTraumatic Brain Injury Research: 0 fractional worksMental Health Research Topics: 0 fractional worksStress Responses and Cortisol: 0 fractional worksNeurotransmitter Receptor Influence on Behavior: 0 fractional works
PharmacologyBiological PsychiatryExperimental and Cognitive PsychologyCognitive Neuroscience4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Treatment of Major Depression Pharmacology 1 works
  2. 2 Tryptophan and brain disorders Biological Psychiatry 0 works
  3. 3 Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes Experimental and Cognitive Psychology 0 works
  4. 4 Pain Management and Placebo Effect Cognitive Neuroscience 0 works
  5. 5 Digital Mental Health Interventions Applied Psychology 0 works
  6. 6 Functional Brain Connectivity Studies Cognitive Neuroscience 0 works
  7. 7 Traumatic Brain Injury Research Epidemiology 0 works
  8. 8 Mental Health Research Topics Experimental and Cognitive Psychology 0 works
  9. 9 Stress Responses and Cortisol Behavioral Neuroscience 0 works
  10. 10 Neurotransmitter Receptor Influence on Behavior Cellular and Molecular Neuroscience 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available63.7%not open36.3%

World: 40% of research is openly available.

with international co-authors73.6%domestic only26.4%

World: 18% is written across borders.

How has Develco Pharma (Switzerland)'s research output changed?

Output in 2022-2025 was 108% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Develco Pharma (Switzerland) as a percentage of every work published that year, 0.000018% in 2024.

still counting0.000020%0.000040%Develco Pharma (Switzerland)0.000013% in 20251990200020102020

Fractional works of Develco Pharma (Switzerland) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Binningen

All research institutions in Binningen

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Develco Pharma (Switzerland). Posts are plain text and can be reported.